Woburn, MA, April 14, 2023

Novatein Biosciences Inc. is excited to announce the launch of its immunoPCR assay development and antibody-DNA conjugation services. With these new offerings, Novatein Biosciences is expanding its suite of research solutions, allowing researchers to achieve ultra-sensitive biomarker detection with minimal sample requirements.

ImmunoPCR, which combines the advantages of PCR amplification and antibody-based detection, is a rapidly growing field in the life sciences. With immunoPCR, researchers can detect low levels of biomarkers with high specificity and sensitivity, using much smaller sample sizes than traditional ELISA-based assays. Novatein Biosciences' immunoPCR assay development services include custom assay design and optimization, as well as the production and validation of immunoPCR reagents, allowing researchers to focus on their research while Novatein Biosciences handles the assay development.

In addition to immunoPCR, Novatein Biosciences is also offering antibody-DNA conjugation services. Antibody-DNA conjugates are an essential tool for researchers working in fields such as epigenetics and chromatin biology, where the analysis of DNA-protein interactions is crucial. With Novatein Biosciences' antibody-DNA conjugation services, researchers can have their antibodies conjugated with high-quality, double-stranded DNA molecules for use in a range of applications, including ChIP-seq and ChIP-qPCR.

"We are thrilled to offer immunoPCR and antibody-DNA conjugation services to our customers," said Dr. John Petrolia, CRO of Novatein Biosciences. "These services represent a significant expansion of our capabilities, allowing researchers to achieve ultra-sensitive biomarker detection and DNA-protein interaction analysis with minimal sample requirements. We look forward to working with researchers to develop customized solutions to meet their specific research needs."

Novatein Biosciences has a proven track record of delivering high-quality, reliable research solutions to its customers. With the addition of immunoPCR assay development and antibody-DNA conjugation services, Novatein Biosciences is further cementing its position as a leader in the life sciences research community.

https://novateinbio.com/content/64-ultrasensitive-elisa-and-immunopcr